"Besuchsregeln – bis auf weiteren gilt an allen Standorten der Salzburger Landeskliniken: • Aufgrund der COVID-Pandemie gelten derzeit eingeschränkte Besuchsregeln. Bitte informieren Sie sich auf unserer Homepage über mögliche Ausnahmen. Patientenversorgung, Prävention und Rehabilitation, Forschung, Lehre und Ausbildung Ob ÄrztInnen, Pflegemitarbeiter oder sonstige Mitarbeiter im Landeskrankenhaus, sie alle sehen es als selbstverständlich, bei der Erbringung von medizinischen Spitzenleistungen den Menschen in seiner Ganzheit zu sehen. Im Mittelpunkt steht immer der Mensch, der von den MitarbeiterInnen des Krankenhauses mit Respekt und Würde behandelt wird."

During the past decade, Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie" are "Fallopian Tube Cancer" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Ovarian Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "PRM-151 (Zinpentraxin Alfa)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".